ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,914Medicare Part D Prescriptions Filled, Including Refills

Rank: 115 out of 288

$407K Total Retail Price of All Prescriptions

Rank: 116 out of 288

281 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 281 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 281 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 6,705 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 301 265 1 1
ATENOLOL 265 250 2 10
AMLODIPINE BESYLATE 260 248 3 6
OMEPRAZOLE 236 203 4 3
LISINOPRIL 215 168 5 4
HYDROCODONE-ACETAMINOPHEN 208 165 S3 6 7
ATORVASTATIN CALCIUM 188 182 7 14
ZOLPIDEM TARTRATE 162 117 8 22
LEVOTHYROXINE SODIUM 158 147 9 2
FUROSEMIDE 143 122 10 5
CITALOPRAM HBR 135 127 11 18
TAMSULOSIN HCL 132 132 12 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 128 106 13 34
METFORMIN HCL 121 67 14 12
WARFARIN SODIUM 120 110 15 9
POTASSIUM CHLORIDE 112 106 16 11
AMLODIPINE BESYLATE-BENAZEPRIL 102 102 17 89
METOPROLOL SUCCINATE 99 88 18 15
METOPROLOL TARTRATE 99 92 18 8
ALENDRONATE SODIUM 98 98 20 20
NEXIUM 93 93 21 43
HYDROCHLOROTHIAZIDE 91 88 22 13
MELOXICAM 90 82 23 44
CRESTOR 79 63 24 26
VERAPAMIL ER 76 66 25 97
AMITRIPTYLINE HCL 75 43 R 26 65
GABAPENTIN 66 53 27 17
BENAZEPRIL HCL 66 64 27 52
LOSARTAN POTASSIUM 64 39 29 16
ISOSORBIDE MONONITRATE ER 61 49 30 35
FLUTICASONE PROPIONATE 60 41 31 41
FAMOTIDINE 59 59 32 68
CYMBALTA 56 46 33 67
LOSARTAN-HYDROCHLOROTHIAZIDE 55 37 34 55
CLONIDINE HCL 53 39 35 70
PRAVASTATIN SODIUM 53 52 35 21
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.